enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Is Johnson & Johnson Stock a Buy? - AOL

   www.aol.com/finance/johnson-johnson-stock-buy...

   In terms of valuation, Johnson & Johnson stock is trading at approximately 17 times management's 2024 earnings-per-share guidance as a forward price-to-earnings (P/E) ratio. This level is well ...

3. Johnson & Johnson stock down despite beat on full-year, Q4 ...

   www.aol.com/finance/johnson-johnson-stock-down...

   A Johnson & Johnson banner is displayed on the front of the New York Stock Exchange (NYSE) in New York City, on Dec. 5, 2023. REUTERS/Brendan McDermid/File Photo (Reuters / Reuters)

4. Is Johnson & Johnson (JNJ) A Good Stock To Buy? - AOL

   www.aol.com/news/johnson-johnson-jnj-good-stock...

   For premium support please call: 800-290-4726 more ways to reach us

5. Is Johnson & Johnson Stock a Buy? - AOL

   www.aol.com/finance/johnson-johnson-stock-buy...

   The company hasn't performed well in recent years, For premium support please call: 800-290-4726 more ways to reach us

6. Johnson & Johnson (JNJ) Stock Sinks As Market Gains ... - AOL

   www.aol.com/news/johnson-johnson-jnj-stock-sinks...

   Johnson & Johnson (JNJ) closed the most recent trading day at $137.17, moving -0.39% from the previous trading session. Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know ...

7. Johnson & Johnson (JNJ) Stock Moves -0.22%: What You ... - AOL

   www.aol.com/news/johnson-johnson-jnj-stock-moves...

   In the latest trading session, Johnson & Johnson (JNJ) closed at $162.81, marking a -0.22% move from the previous day.

8. Johnson & Johnson (JNJ) Stock Moves -0.12%: What You ... - AOL

   www.aol.com/news/johnson-johnson-jnj-stock-moves...

   Johnson & Johnson (JNJ) closed at $169.27 in the latest trading session, marking a -0.12% move from the prior day.

9. 3 Healthcare Stocks to Trade: UNH, JNJ and PFE - AOL

   www.aol.com/news/3-healthcare-stocks-trade-unh...

   Even under normal circumstances, the healthcare stocks are prone to headline risk. Case in point, what happened to Sarepta (NASDAQ:SRPT) last night when the stock fell 15% on FDA news. Add to it ...